Sarepta Therapeutics' Elevidys for DMD shows revenue potential, with market cap justified at $11.4bn and potential for >50% ...
The FDA established its accelerated approval program in 1992 to allow drugs to reach the market quickly for life-threatening ...
In a report released today, Tazeen Ahmad from Bank of America Securities maintained a Hold rating on Kymera Therapeutics (KYMR – Research ...
In a report released today, Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Vertex Pharmaceuticals (VRTX – Research ...
GlobalData on MSN16h
Santhera launches DMD therapy in the UK following NICE nodSanthera Pharmaceuticals has started launch preparations for its DMD drug Agamree (vamorolone) in the UK, after a ...
REGENXBIO's partnership with Nippon Shinyaku provides $110M upfront, ensuring a cash runway for gene therapy programs in MPS ...
On Wednesday, Beacon Health System hospital began strongly encouraging visitors to wear masks when directly interacting with hospitalized patients due to an increase of respiratory illness in the ...
You know the green tiles are iconic. You can't help but play along when Wheel Of Fortune is on. The legendary game show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback